Podcast Episodes

Back to Search
Pharmaceutical Executive Daily: Sanofi Appoints Belén Garijo as CEO
Pharmaceutical Executive Daily: Sanofi Appoints Belén Garijo as CEO

In today’s Pharmaceutical Executive Daily, Sanofi formally confirms its CEO leadership following a shareholder vote, US prescription drug spending is…

2 months, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: Rocket Pharmaceuticals Sells Pediatric Disease Priority Review Voucher
Pharmaceutical Executive Daily: Rocket Pharmaceuticals Sells Pediatric Disease Priority Review Voucher

In today's Pharmaceutical Executive Daily, Rocket Pharmaceuticals announces a $180 million sale of its rare pediatric disease priority review voucher…

2 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Breztri
Pharmaceutical Executive Daily: FDA Approves Breztri

In today's Pharmaceutical Executive Daily, we cover Sun Pharma and IMG Pharma's respective acquisitions, FDA's approval of AstraZeneca's Breztri, and…

2 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Caplyta for Adults with Schizophrenia
Pharmaceutical Executive Daily: FDA Approves Caplyta for Adults with Schizophrenia

In today's Pharmaceutical Executive Daily, Eli Lilly announces a definitive agreement to acquire Ajax Therapeutics for up to $2.3 billion, adding a f…

2 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Issues CRL to AbbVie
Pharmaceutical Executive Daily: FDA Issues CRL to AbbVie

In today’s Pharmaceutical Executive Daily, the FDA issues a complete response letter to AbbVie for a biologics license application, Regeneron moves t…

2 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Expands Approvals for Tzield and Dupixent
Pharmaceutical Executive Daily: FDA Expands Approvals for Tzield and Dupixent

In today’s Pharmaceutical Executive Daily, the FDA expands the use of Tzield to young children to delay the onset of stage 3 type 1 diabetes, Dupixen…

2 months, 2 weeks ago

Short Long
View Episode
The Ron Lanton Report: Where Innovations Happens
The Ron Lanton Report: Where Innovations Happens

In this episode, Ron Lanton examines how geography is becoming a central strategic variable in healthcare, as policy, trade dynamics, and infrastruct…

2 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Idvynso Receives FDA Approval
Pharmaceutical Executive Daily: Idvynso Receives FDA Approval

In today’s Pharmaceutical Executive Daily, the FDA approves a new treatment for HIV-1 infection in adults, Amazon One Medical launches a GLP-1 weight…

2 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: UnitedHealth Raises Full-Year Profit Forecast
Pharmaceutical Executive Daily: UnitedHealth Raises Full-Year Profit Forecast

In today’s Pharmaceutical Executive Daily, UnitedHealth raises its full-year profit forecast following stronger-than-expected first-quarter results, …

2 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics
Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics

In today’s Pharmaceutical Executive Daily, Eli Lilly enters a $7 billion agreement to acquire Kelonia Therapeutics, the Trump administration issues a…

2 months, 3 weeks ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us